4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-001247
Options or other derivatives
- President and CEO acquired 97,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2018-01-31 | Grant or award · Stock Option (right to buy) | +97,000 | 97,000 | D: show line 1 in the form |
Loading xslF345X03/f4013118nkidronnadav_oramed.xml…